Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study


Por: Compta, Y, Dias, SP, Giraldo, DM, Perez-Soriano, A, Munoz, E, Saura, J, Fernandez, M, Bravo, P, Camara, A, Pulido-Salgado, M, Painous, C, Rios, J, Marti, MJ, Pagonabarraga, J, Valldeoriola, F, Hernandez-Vara, J, Classen, SJ, Puente, V, Pont, C, Caballol, N, Tolosa, E, Bayes, A, Campdelacreu, J, de Fabregues, O, Avila, A, Calopa, M, Gaig, C, Fabregat, N, Pastor, P, Aguilar, M, Pujol, M, Sanchez, A, Planellas, L, Ezquerra, M, Fernandez-Santiago, R, Botta, T, Tartaglia, G

Publicada: 1 ago 2019
Resumen:
Introduction: Neuroinflammation is a potential player in neurodegenerative conditions, particularly the aggressive ones, such as multiple system atrophy (MSA). Previous reports on cytokine levels in MSA using serum or cerebrospinal fluid (CSF) have been inconsistent, including small samples and a limited number of cytokines, often without comparison to Parkinson's disease (PD), a main MSA differential diagnosis. Methods: Cross-sectional study of CSF levels of 38 cytokines using a multiplex assay in 73 participants: 39 MSA patients (19 with parkinsonian type [MSAp], 20 with cerebellar type [MSAc]; 31 probable, 8 possible), 19 PD patients and 15 neurologically unimpaired controls. None of the participants was under non-steroidal anti-inflammatory drugs at the time of the lumbar puncture. Results: There were not significant differences in sex and age among participants. In global non-parametric comparisons FDR-corrected for multiple comparisons, CSF levels of 5 cytokines (FGF-2, IL-10, MCP-3, IL-12p40, MDC) differed among the three groups. In pair-wise FDR-corrected non-parametric comparisons 12 cytokines (FGF-2, eotaxin, fractalkine, IFN-alpha 2, IL-10, MCP-3, IL-12p40, MDC, IL-17, IL-7, MIP-1 beta, TNF-alpha) were significantly higher in MSA vs. non-MSA cases (PD + controls pooled together). Of these, MCP-3 and MDC were the most significant ones, also differed in MSA vs. PD, and were significant MSA-predictors in binary logistic regression models and ROC curves adjusted for age. CSF levels of fractalkine and MIP-1 alpha showed a strong and significant positive correlation with UMSARS-2 scores. Conclusion: Increased CSF levels of cytokines such as MCP-3, MDC, fractalkine and MIP-1 alpha deserve consideration as potential diagnostic or severity biomarkers of MSA.

Filiaciones:
Compta, Y:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Dias, SP:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

 Ctr Hosp Lisboa Cent, Dept Neurol, Lisbon, Portugal

Giraldo, DM:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Perez-Soriano, A:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Munoz, E:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Saura, J:
 Univ Barcelona, Biochem & Mol Biol Unit, Dept Biomed, Sch Med,Inst Neurociencies, Catalonia, Spain

Fernandez, M:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Bravo, P:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Camara, A:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Pulido-Salgado, M:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Painous, C:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Rios, J:
 Univ Autonoma Barcelona, IDIBAPS, Med Stat Core Facil, Catalonia, Spain

 Univ Autonoma Barcelona, Fac Med, Biostat Unit, Catalonia, Spain

Marti, MJ:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Pagonabarraga, J:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

 Hosp Santa Creu & Sant Pau, Movement Disorders Unit, Barcelona, Catalonia, Spain

Valldeoriola, F:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Hernandez-Vara, J:
 Hosp Valle De Hebron, Movement Disorders Unit, Barcelona, Catalonia, Spain

Classen, SJ:
 Hosp Bellvitge Princeps Espanya, Movement Disorders Unit, Barcelona, Catalonia, Spain

Puente, V:
 Hosp Mar, Movement Disorders Unit, Barcelona, Catalonia, Spain

Pont, C:
 Hosp Gen Granollers, Granollers, Catalonia, Spain

Caballol, N:
 Hosp St Joan Despi Moises Broggi Consorci Sanitar, Movement Disorders Unit, Lhospitalet De Llobregat, Catalonia, Spain

Tolosa, E:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Bayes, A:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

 Ctr Med Teknon, Movement Disorders Unit, Barcelona, Catalonia, Spain

Campdelacreu, J:
 Hosp Bellvitge Princeps Espanya, Movement Disorders Unit, Barcelona, Catalonia, Spain

de Fabregues, O:
 Hosp Valle De Hebron, Movement Disorders Unit, Barcelona, Catalonia, Spain

Avila, A:
 Hosp St Joan Despi Moises Broggi Consorci Sanitar, Movement Disorders Unit, Lhospitalet De Llobregat, Catalonia, Spain

Calopa, M:
 Hosp Bellvitge Princeps Espanya, Movement Disorders Unit, Barcelona, Catalonia, Spain

Gaig, C:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Fabregat, N:
 Hosp Plato, Barcelona, Catalonia, Spain

Pastor, P:
 Univ Hosp Mutua Terrassa, Neurol, Movement Disorders Unit, Terrassa, Catalonia, Spain

Aguilar, M:
 Univ Hosp Mutua Terrassa, Neurol, Movement Disorders Unit, Terrassa, Catalonia, Spain

Pujol, M:
 Hosp Santa Maria Lleida, Lleida, Catalonia, Spain

Sanchez, A:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Planellas, L:
 Univ Barcelona, Parkinsons Dis & Movement Disorders Unit, Inst Neurociencies, Hosp Clin IDIBAPS CIBERNED European Reference Net, Catalonia, Spain

Ezquerra, M:
 IDIBAPS, Lab Parkinson Dis & Other Neurodegenerat Movement, Barcelona, Catalonia, Spain

Fernandez-Santiago, R:
 IDIBAPS, Lab Parkinson Dis & Other Neurodegenerat Movement, Barcelona, Catalonia, Spain

Botta, T:
 Univ Pompeu Fabra, ICREA, Ctr Genom Regulat CRG, Gene Funct & Evolut Grp, Barcelona, Catalonia, Spain

Tartaglia, G:
 Univ Pompeu Fabra, ICREA, Ctr Genom Regulat CRG, Gene Funct & Evolut Grp, Barcelona, Catalonia, Spain
ISSN: 13538020
Editorial
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 65 Número:
Páginas: 3-12
WOS Id: 000491682900002
ID de PubMed: 31178335
imagen Green Published

MÉTRICAS